A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

Taking GLP-1 drugs for diabetes has been shown to lower the risk of ​adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the ‌odds of ...

Nano-therapeutics represent a transformative advancement in precision cancer medicine, offering the promise of more effective and targeted treatment options. By harnessing the unique properties of ...

This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from ...

House Speaker Matt Hall, R-Richland township, described the substance as “similar to heroin.” State Rep. Cam Cavitt, R-Cheboygan, called its sale a “crisis.” And Patti Wheeler, a New Jersey resident ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

A new study of 333,000 patients found that stopping weight loss drugs like Ozempic reverses key health benefits.

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

Drugs known as GLP-1 medications, which are widely used for treating type 2 diabetes and helping with weight loss, have ...

Pharmaceutical residues increasingly enter ecosystems across the drug life cycle, prompting calls for coordinated global action grounded in One Health principles.